^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

NDV HUJ

i
Other names: NDV HUJ, OV-001, TV-7000
Associations
Trials
Company:
Theravir Management
Drug class:
Immunostimulant
Related drugs:
Associations
Trials
over1year
Evaluation treatment planning system for oropharyngeal cancer patient using machine learning. (PubMed, Appl Radiat Isot)
Organs at risk were observed that the volume of L-Eye in clinical plan (AF) for the case1 treatment planning could be successfully used ensuring efficiency and lower than MLVMAT and MLVMAT-org plans were 372 cGy, 697 cGy and 667 cGy respectively, while showed case2, case3, case4 and case5 are better to protect the critical organs in ML plan compare with a clinical plan. DHI for the PTV-7000 and PTV-5425 is between 1 and 1.34, While DCI for PTV-7000 and PTV-5425 is between 0.98 and 1.
Journal • Machine learning
|
NDV HUJ